Financial Gravity Asset Management, Inc. Biomarin Pharmaceutical Inc Transaction History

Financial Gravity Asset Management, Inc.

  • $355 Billion
  • Q1 2024

A detailed history of Financial Gravity Asset Management, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 7 shares of BMRN stock, worth $566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 13 46.15%
Holding current value
$566
Previous $1.49 Million 56.05%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 26, 2024
SELL
$83.81 - $99.0 $502 - $594
-6 Reduced 46.15%
7 $654,000
Q1 2024

May 13, 2024
BUY
$83.81 - $99.0 $335 - $396
4 Added 30.77%
17 $1.52 Million
Q4 2023

Jun 26, 2024
SELL
$76.22 - $98.51 $304 - $394
-4 Reduced 23.53%
13 $1.49 Million
Q3 2023

Nov 15, 2023
SELL
$85.07 - $94.48 $6,295 - $6,991
-74 Reduced 85.06%
13 $1,000
Q2 2023

Aug 08, 2023
SELL
$86.68 - $100.3 $866 - $1,003
-10 Reduced 10.31%
87 $1.1 Million
Q1 2023

May 12, 2023
SELL
$87.74 - $117.27 $526 - $703
-6 Reduced 5.83%
97 $1.39 Million
Q4 2022

Feb 15, 2023
SELL
$80.93 - $108.63 $74,212 - $99,613
-917 Reduced 89.9%
103 $1.39 Million
Q3 2022

Nov 03, 2022
BUY
$82.16 - $96.94 $1,971 - $2,326
24 Added 2.41%
1,020 $1.22 Million
Q2 2022

Aug 05, 2022
BUY
$71.48 - $86.85 $5,146 - $6,253
72 Added 7.79%
996 $1.19 Million
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $16,341 - $20,391
-220 Reduced 19.23%
924 $1.11 Million
Q4 2021

Feb 11, 2022
BUY
$71.72 - $91.47 $81,043 - $103,361
1,130 Added 8071.43%
1,144 $1.27 Million
Q2 2021

Aug 11, 2021
SELL
$75.51 - $84.79 $604 - $678
-8 Reduced 36.36%
14 $83,000
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $4,932 - $5,985
-66 Reduced 75.0%
22 $1.67 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $6,389 - $7,937
88 New
88 $7,000
Q2 2020

Aug 13, 2020
SELL
$79.55 - $124.22 $45,661 - $71,302
-574 Closed
0 $0
Q1 2020

May 12, 2020
SELL
$71.37 - $96.85 $28,405 - $38,546
-398 Reduced 40.95%
574 $48,000
Q4 2019

Feb 28, 2020
SELL
$64.27 - $86.37 $31,363 - $42,148
-488 Reduced 33.42%
972 $85,000
Q3 2019

Oct 15, 2019
SELL
$67.4 - $85.11 $22,242 - $28,086
-330 Reduced 18.44%
1,460 $98,000
Q2 2019

Jul 26, 2019
SELL
$80.35 - $93.9 $30,291 - $35,400
-377 Reduced 17.4%
1,790 $153,000
Q1 2019

Apr 19, 2019
BUY
$84.2 - $98.62 $7,241 - $8,481
86 Added 4.13%
2,167 $194,000
Q3 2018

Oct 31, 2018
SELL
$93.92 - $105.72 $9,485 - $10,677
-101 Reduced 4.63%
2,081 $195,000
Q2 2018

Aug 14, 2018
SELL
$76.01 - $99.03 $14,061 - $18,320
-185 Reduced 7.82%
2,182 $221,000
Q1 2018

May 23, 2018
BUY
$77.67 - $92.63 $183,844 - $219,255
2,367 New
2,367 $195,000

Others Institutions Holding BMRN

# of Institutions
623
Shares Held
181M
Call Options Held
1.73M
Put Options Held
1.73M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email